Shares of Bradmer Pharmaceuticals Inc. (TSE:GLX – Get Free Report) have been given an average recommendation of “Strong Buy” by the seven ratings firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have given a strong buy recommendation to the company.
Separately, Citizens Jmp raised shares of Bradmer Pharmaceuticals to a “strong-buy” rating in a research note on Tuesday, December 9th.
Bradmer Pharmaceuticals Price Performance
Read More
- Five stocks we like better than Bradmer Pharmaceuticals
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Bradmer Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bradmer Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
